Search results
30 lip 2024 · Fact Sheet. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products.
29 lut 2024 · A Guide to our New Product Pipeline Visualization. We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development! Find out more.
This page contains information about Pfizer's scientific breakthroughs for patients across multiple therapeutic areas in 2021, spotlights on noteworthy Pfizer colleagues and Bold Moves update charting how Pfizer is progressing toward its purpose of breakthroughs that change patients' lives.
Fact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, and also includes information about the U.S. Food and Drug Administration (FDA)-licensed vaccine,
Performance. 2021 was a year in which we set all-time highs in several financial categories — including Revenue and Adjusted Diluted EPS. Learn more about our performance on our. Investor site. Financial Performance. Three-year summary for the years ended December 31. Millions (Except Per Common Share Data) % Change.
22 sie 2024 · The Pfizer-BioNTech COVID-19 Vaccine is a vaccine for use in individuals 6 months through 11 years of age to prevent COVID-19. The FDA has authorized the emergency use of the...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
